世界のニキビ治療薬市場予測2022年-2027年

【英語タイトル】Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが出版した調査資料(IMARC22OT0009)・商品コード:IMARC22OT0009
・発行会社(調査会社):IMARC
・発行日:2022年8月22日
・ページ数:147
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥369,852見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥517,852見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥665,852見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

IMARC社では、世界のニキビ治療薬市場規模が2021年61億ドルから2027年91億ドルに達し、2022年から2027年まで年平均7.4%成長すると予測しています。本調査レポートでは、ニキビ治療薬の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、ニキビ種類別(面皰性、炎症性、包嚢、術後/創傷)分析、薬物クラス別(レチノイド、抗生物質、ホルモン剤、配合剤、その他)分析、薬種類別(OTC医薬品、処方薬)分析、投与経路別(外用剤、経口剤、注射剤)分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Allergan Plc、Bausch Health Companies Inc.、Bayer Aktiengesellschaft、Cipher Pharmaceuticals Inc.、Galderma Holding SA、Johnson & Johnson、Pfizer Inc.、Reckitt Benckiser Group Plc、Skinvisible Pharmaceuticals Inc.、Sun Pharmaceutical Industries Limited、Teva Pharmaceutical Industries Ltd.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のニキビ治療薬市場規模:ニキビ種類別
- 面皰性ニキビ治療薬の市場規模
- 炎症性ニキビ治療薬の市場規模
- 包嚢ニキビ治療薬の市場規模
- 術後/創傷ニキビ治療薬の市場規模
・世界のニキビ治療薬市場規模:薬物クラス別
- レチノイドニキビ治療薬の市場規模
- 抗生物質ニキビ治療薬の市場規模
- ホルモン剤ニキビ治療薬の市場規模
- 配合剤ニキビ治療薬の市場規模
- その他薬物クラスのニキビ治療薬市場規模
・世界のニキビ治療薬市場規模:薬種類別
- OTC医薬品におけるニキビ治療薬の市場規模
- 処方薬におけるニキビ治療薬の市場規模
・世界のニキビ治療薬市場規模:投与経路別
- 外用ニキビ治療薬の市場規模
- 経口用ニキビ治療薬の市場規模
- 注射用ニキビ治療薬の市場規模
・世界のニキビ治療薬市場規模:地域別
- 北米のニキビ治療薬市場規模
- アジア太平洋のニキビ治療薬市場規模
- ヨーロッパのニキビ治療薬市場規模
- 中南米のニキビ治療薬市場規模
- 中東・アフリカのニキビ治療薬市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

The global acne drugs market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 7.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Acne drugs refer to the medications used for treating a dermatological infection characterized by the inflammation in the hair follicles on skin. It is usually caused by hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate intake of water and excessive consumption of sugars, salts or carbohydrates. Some of the commonly used acne drugs include topical medications, such as retinoids, salicylic and azelaic acid-based ointments and dapsone-based gels, along with antibiotics, anti-androgen agents and isotretinoin. These drugs minimize the levels of oil production in the body, speed up skin cell turnover, control acne breakouts, reduce scarring and damage to the skin and prevent inflammation.

The increasing prevalence of skin-related diseases, such as acne vulgaris, is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the benefits of using premium skin care products is driving the market growth. The market is further being driven by the development of effective therapeutics and treatment alternatives with reduced side effects and high potential. Increasing consumer preference for products manufactured using natural ingredients is acting as another growth-inducing factor. Manufacturers are, therefore, developing products infused with natural herbs and organic ingredients, such as aloe vera, green tea, honey, jojoba oil and rosemary, for treating acne. Other factors, including rising expenditure capacities of consumers, along with the proliferation of online retail platforms that offer customized acne drugs according to the user’s skin type, are expected to create a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global acne drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on acne type, drug class, drug type and route of administration.

Breakup by Acne Type:

Comedonal
Inflammatory
Cystic
Postsurgical/Wound

Breakup by Drug Class:

Retinoids
Antibiotics
Hormonal Agents
Combination Drugs
Others

Breakup by Drug Type:

OTC Drugs
Prescription Drugs

Breakup by Route of Administration:

Topical
Oral
Injectable

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, Cipher Pharmaceuticals Inc., Galderma Holding SA, Johnson & Johnson, Pfizer Inc., Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:
How has the global acne drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global acne drugs market?
What are the key regional markets?
What is the breakup of the market based on the acne type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global acne drugs market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Acne Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Acne Type
6.1 Comedonal
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inflammatory
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cystic
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Postsurgical/Wound
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Retinoids
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Antibiotics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hormonal Agents
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Combination Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Drug Type
8.1 OTC Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Prescription Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Topical
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Injectable
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Allergan Plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bausch Health Companies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Cipher Pharmaceuticals Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Galderma Holding SA
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Reckitt Benckiser Group Plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Skinvisible Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Sun Pharmaceutical Industries Limited
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Teva Pharmaceutical Industries Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis



★調査レポート[世界のニキビ治療薬市場予測2022年-2027年] (コード:IMARC22OT0009)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のニキビ治療薬市場予測2022年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆